Literature DB >> 8416808

X-ray crystallographic structure of a papain-leupeptin complex.

E Schröder1, C Phillips, E Garman, K Harlos, C Crawford.   

Abstract

The three-dimensional structure of the papain-leupeptin complex has been determined by X-ray crystallography to a resolution of 2.1 A (overall R-factor = 19.8%). The structure indicates that: (i) leupeptin contacts the S subsites of the papain active site and not the S' subsites; (ii) the 'carbonyl' carbon atom of the inhibitor is covalently bound by the Cys-25 sulphur atom of papain and is tetrahedrally coordinated; (iii) the 'carbonyl' oxygen atom of the inhibitor faces the oxyanion hole and makes hydrogen bond contacts with Gln-19 and Cys-25.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416808     DOI: 10.1016/0014-5793(93)81128-m

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases.

Authors:  K S Makarova; L Aravind; E V Koonin
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

2.  Two crystal structures of the leupeptin-trypsin complex.

Authors:  I V Kurinov; R W Harrison
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

3.  Design of potent and selective human cathepsin K inhibitors that span the active site.

Authors:  S K Thompson; S M Halbert; M J Bossard; T A Tomaszek; M A Levy; B Zhao; W W Smith; S S Abdel-Meguid; C A Janson; K J D'Alessio; M S McQueney; B Y Amegadzie; C R Hanning; R L DesJarlais; J Briand; S K Sarkar; M J Huddleston; C F Ijames; S A Carr; K T Garnes; A Shu; J R Heys; J Bradbeer; D Zembryki; L Lee-Rykaczewski; I E James; M W Lark; F H Drake; M Gowen; J G Gleason; D F Veber
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Intrinsic evolutionary constraints on protease structure, enzyme acylation, and the identity of the catalytic triad.

Authors:  Andrew R Buller; Craig A Townsend
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 5.  Microbial inhibitors of cysteine proteases.

Authors:  Mateusz Kędzior; Rafał Seredyński; Jan Gutowicz
Journal:  Med Microbiol Immunol       Date:  2016-04-05       Impact factor: 3.402

Review 6.  Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death.

Authors:  N A Thornberry; S M Molineaux
Journal:  Protein Sci       Date:  1995-01       Impact factor: 6.725

7.  Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules.

Authors:  L C Pedersen; V C Yee; P D Bishop; I Le Trong; D C Teller; R E Stenkamp
Journal:  Protein Sci       Date:  1994-07       Impact factor: 6.725

8.  Variation in the pH-dependent pre-steady-state and steady-state kinetic characteristics of cysteine-proteinase mechanism: evidence for electrostatic modulation of catalytic-site function by the neighbouring carboxylate anion.

Authors:  Syeed Hussain; Surapong Pinitglang; Tamara S F Bailey; James D Reid; Michael A Noble; Marina Resmini; Emrys W Thomas; Richard B Greaves; Chandra S Verma; Keith Brocklehurst
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

9.  Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG.

Authors:  Katja Wenig; Lorenz Chatwell; Ulrich von Pawel-Rammingen; Lars Björck; Robert Huber; Peter Sondermann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

10.  Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases.

Authors:  Siiri E Iismaa; Sara Holman; Merridee A Wouters; Laszlo Lorand; Robert M Graham; Ahsan Husain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.